Secretary Robert F. Kennedy Jr. has made psychiatric medications a focus of his review of the country’s childhood chronic ...

The pathologists group wants the HHS to terminate the regulation in light of an executive order from President Trump that calls for federal agencies to “alleviate unnecessary regulatory burdens.” ...

Patient advocacy groups had decried the firings, and lobbying groups rushed to save some slots that were in part funded by ...

Rare Disease Symposium, held on February 5 in Boston and virtually, gathered patient advocates and caregivers, providers, ...

Childhood psychiatrists insist the drugs, for attention-deficit/hyperactivity disorder (ADHD) and depression, are nonaddictive and proven safe and say they are more concerned about young Americans ...

Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.

While it was set to become effective today (Feb. 25), the final rule is delayed until April 28, according to the Dept. of ...